Eli Lilly's Phase 3 brenipatide trials (2,200 patients) are the largest addiction trials yet for this drug class [1]
But if something is irritating your esophagus lining for a long time, youre likely to have symptoms from that
If you hold the vial up to light and the solution looks anything other than perfectly clear, do not use it
The overall incidence of reported adverse reactions of hypoglycemia in patients with type 2 diabetes inadequately controlled on diet and exercise was 0.6% in patients given placebo, 0.6% in patients given sitagliptin alone, 0.8% in patients given metformin immediate-release alone, and 1.6% in patients given sitagliptin in combination with metformin immediate-release
A combined outcome of steatohepatitis resolution and fibrosis improvement was achieved in 32.7% of semaglutide users and in 16.1% of the placebo group
Mounjaro is the brand name for tirzepatide, a dual GIP and GLP-1 receptor agonist